CClinicalTrials.gg
CompletedNCT04661228PsykHUNTUpdated Dec 11, 2020

Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)

An observational study in Mental Disorders, Substance Use Disorders and Treatment, sponsored by Norwegian Institute of Public Health. Completed at 1 site in Norway. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-11.

Sponsored by Norwegian Institute of Public Health · Observational

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
4,242
Ages
20 Years to 65 Years
Sex
All
01

Study summary

The aims of this observational survey are to i) gather experience on how to conduct a prevalence study of mental disorders in the Norwegian setting, ii) collect data on the prevalence, risk factors and consequences of mental and substance use disorders, iii) collect data on treatment coverage for mental and substance use disorders, iv) conduct a thorough nonparticipation analysis.

Read the detailed description

The psychiatric survey was a sub-project in the fourth wave of the Trøndelag Health Study (HUNT4), conducted on HUNT4 participants aged 20 to 65 years from the geographical areas Nord-Trøndelag and the city of Trondheim. The targeted sample size was 4,000 participants, and 16,602 persons from the study population of HUNT4 participants were invited to reach this goal. The only exclusion criterion was insufficient understanding of Norwegian or English. The investigators had complete lists with postal addresses and mobile phone numbers for all eligible participants as well as information about date of birth and gender. Potential participants were sampled in repeated probability sampling draws over the course of the data-collection period, which lasted from November 2nd 2018 to September 18th 2020. Younger persons were oversampled to adjust for the expected larger nonparticipation among these age-groups. The predesignated participants were informed about the project through postal letters. A week after receipt of the letter, each received an SMS with information on how to sign up for the psychiatric interview. One SMS reminder was sent to persons who did not respond to the initial invitation. The investigators made four contact attempts to schedule the interview amongst those who registered; three by phone and one final by SMS. All participants received a $30 gift card as a token of appreciation. Computer assisted face-to-face or telephone interviews were conducted by trained and certified interviewers at local field stations. The World Health Organization (WHO) Composite International Diagnostic Interview, fifth version (CIDI 5.0) was used as instrument in the data-collection.

02

Conditions studied

  • Mental Disorders
  • Substance Use Disorders
  • Treatment
  • Participation

Keywords

  • Mental Disorders
  • Substance Use Disorders
  • Treatment
  • Participation
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 4,242 is above the median of 250 across 296 observational studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Norwegian Institute of Public Health is the lead sponsor of 49 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Sub-sample of participants from the fourth round of the Trøndelag Health Study (HUNT4). All residents in Trøndelag county of Norway above age 18 were invited to the HUNT4 study.

Inclusion criteria

  • Sufficient understanding of Norwegian or English to conduct the interview

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
4,242 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testComposite International Diagnostic Interview 5th version (CIDI 5.0)

    Observational study assessing prevalence of mental and substance use disorders in the general population

06

What researchers measure

Primary outcomes

  1. Prevalence of mental and substance use disorders in the general population, and by age, gender, educational attainment and urban/rural residency

    Mental and substance use disorders assessed in standardised diagnostic interviews employing the Composite International Diagnostic Interview (CIDI 5.0). Diagnostis criteria after ICD-10 and DSM-V.

    Time frame: November 2018 to September 2020

Secondary outcomes

  1. The characteristics of nonparticipants in a psychiatric diagnostic survey

    Compare characteristics of participants versus nonparticipants in the survey in terms of age, gender, educational attainment, mental health symptoms, alcohol use, and use of health services for mental health problems. Data will be retrieved from the HUNT4 study, and official administrative registries and health registries.

    Time frame: November 2018 to September 2020

  2. The treatment gap for mental and substance use disorders in the general population

    Quantify the gap between perceived need for treatment for mental health problems and received adequate treatment using data from CIDI in linkage with data from official health registries.

    Time frame: November 2018 to September 2021

07

Study locations

1 site
  • Norwegian Institute of Public Health
    Oslo, Norway
08

References and documents

Individual participant data

Plan to share: Yes — Researchers may gain access to participant data by contacting the PsykHUNT publication committee (anne.reneflot@fhi.no). Approval from the Norwegian Regional Committee for Medical and Health Research Ethics (https://helseforskning.etikkom.no) is a pre-requirement. The PsykHUNT dataset is administrated by the HUNT databank. Guidelines for access to PsykHUNT data are found at https://www.ntnu.edu/hunt/data.

Supporting information: Study protocol, Sap, Icf, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04661228
Lead sponsor
Norwegian Institute of Public Health
Collaborators
Norwegian University of Science and Technology
Responsible party
Sponsor
First posted
Dec 10, 2020
Start date
Nov 2, 2018
Primary completion
Sep 18, 2020
Completion
Sep 18, 2020
Last update
Dec 11, 2020

Study contacts

Anne Reneflot, PhD
principal investigator · Norwegian IPH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion